Abstract
Caspase-independent death mechanisms have been shown to execute apoptosis in many types of neuronal injury. P53 has been identified as a key regulator of neuronal cell death after acute injury such as DNA damage, ischemia, and excitotoxicity. Here, we demonstrate that p53 can induce neuronal cell death via a caspase-mediated process activated by apoptotic activating factor-1 (Apaf1) and via a delayed onset caspase-independent mechanism. In contrast to wild-type cells, Apaf1-deficient neurons exhibit delayed DNA fragmentation and only peripheral chromatin condensation. More importantly, we demonstrate that apoptosis-inducing factor (AIF) is an important factor involved in the regulation of this caspase-independent neuronal cell death. Immunofluorescence studies demonstrate that AIF is released from the mitochondria by a mechanism distinct from that of cytochrome-c in neurons undergoing p53-mediated cell death. The Bcl-2 family regulates this release of AIF and subsequent caspase-independent cell death. In addition, we show that enforced expression of AIF can induce neuronal cell death in a Bax- and caspase-independent manner. Microinjection of neutralizing antibodies against AIF significantly decreased injury-induced neuronal cell death in Apaf1-deficient neurons, indicating its importance in caspase-independent apoptosis. Taken together, our results suggest that AIF may be an important therapeutic target for the treatment of neuronal injury.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies / pharmacology
-
Apoptosis / physiology*
-
Apoptosis Inducing Factor
-
Apoptotic Protease-Activating Factor 1
-
Brain / cytology
-
Brain / embryology*
-
Brain / enzymology
-
Camptothecin / pharmacology
-
Caspase Inhibitors
-
Caspases / metabolism*
-
Cell Survival / drug effects
-
Cell Survival / physiology
-
Cells, Cultured
-
DNA Damage / drug effects
-
DNA Damage / physiology
-
Enzyme Inhibitors / pharmacology
-
Flavoproteins / genetics
-
Flavoproteins / metabolism*
-
Gene Frequency / physiology
-
In Situ Nick-End Labeling
-
Membrane Proteins / genetics
-
Membrane Proteins / metabolism*
-
Mice
-
Mice, Knockout
-
Mitochondria / genetics
-
Mitochondria / metabolism
-
Neurodegenerative Diseases / drug therapy
-
Neurodegenerative Diseases / enzymology*
-
Neurodegenerative Diseases / physiopathology
-
Neurons / cytology
-
Neurons / enzymology*
-
Proteins / genetics
-
Proteins / metabolism*
-
Proto-Oncogene Proteins / genetics
-
Proto-Oncogene Proteins / metabolism
-
Proto-Oncogene Proteins c-bcl-2 / genetics
-
Proto-Oncogene Proteins c-bcl-2 / metabolism
-
Transfection
-
Tumor Suppressor Protein p53 / drug effects
-
Tumor Suppressor Protein p53 / genetics
-
Tumor Suppressor Protein p53 / metabolism
-
bcl-2-Associated X Protein
Substances
-
Antibodies
-
Apaf1 protein, mouse
-
Apoptosis Inducing Factor
-
Apoptotic Protease-Activating Factor 1
-
Bax protein, mouse
-
Caspase Inhibitors
-
Enzyme Inhibitors
-
Flavoproteins
-
Membrane Proteins
-
AIFM1 protein, mouse
-
Proteins
-
Proto-Oncogene Proteins
-
Proto-Oncogene Proteins c-bcl-2
-
Tumor Suppressor Protein p53
-
bcl-2-Associated X Protein
-
Caspases
-
Camptothecin